RT @ShimaghavimiMD: @aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherap…
RT @ShimaghavimiMD: @aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherap…
RT @ShimaghavimiMD: @aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherap…
RT @ShimaghavimiMD: @aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherap…
RT @ShimaghavimiMD: @aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherap…
@aparna1024 @TumorBoardTues #TumorBoardTuesdays The combination of a liver-first strategy and neoadjuvant chemotherapy is a possible treatment of choice to cure colorectal cancer with simultaneous advanced colorectal liver metastases https://t.co/qNFkEv
New article: Complete remission of multiple liver metastases with only partial response of the primary rectal cancer after neoadjuvant chemotherapy. https://t.co/9W43FEZpsu #pancreaticcancer #oncology